FindTrial
Sign In

Comparison of remimazolam and propofol in postoperative delirium in elderly patients undergoing radical resection of colon cancer

Comparison of remimazolam and propofol in postoperative delirium in elderly patients undergoing radical resection of colon cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076384
Enrollment
Unknown
Registered
2023-10-07
Start date
2023-10-09
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium

Interventions

Group R:Remimazolam
Group P:Propofol

Sponsors

Cangzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Elderly patients aged >=65 years; 2. Patients undergoing radical resection of colon cancer; 3. ASA grade I to III.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of mental illness or a history of central nervous system disease; 2. A history of substance abuse; 3. History of alcoholism .

Design outcomes

Primary

MeasureTime frame
Postoperative delirium;—

Secondary

MeasureTime frame
Postoperative Pain;Adverse reactions;—

Countries

China

Contacts

Public ContactLiu Tianlin

Cangzhou Central Hospital

1377689587@qq.com+86 180 0337 0383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026